Michael Dörks
Impact in
- Geriatrics and Gerontology top 2%
- Pharmaceutical Practices and Patient Outcomes
- Toxicology top 10%
- Pharmacovigilance and Adverse Drug Reactions
Papers in
-
- Pharmaceutical Practices and Patient Outcomes 12
-
- Pharmaceutical studies and practices 5
- Co-authors
- Falk Hoffmann (20 shared papers)Guido Schmiemann (10 shared papers)Stefan Herget‐Rosenthal (9 shared papers)Edeltraut Garbe (7 shared papers)Katharina Allers (3 shared papers)Antje Timmer (3 shared papers)Ingo Langner (3 shared papers)Kathrin Jobski (10 shared papers)
In The Last Decade
Michael Dörks
29 papers receiving 458 citations
Peers
Comparison fields: 5 of 60
- Geriatrics and Gerontology 153
- Toxicology 27
- Pediatrics, Perinatology and Child Health 59
- Psychiatry and Mental health 77
- Pharmacology 43
Countries citing papers authored by Michael Dörks
This map shows the geographic impact of Michael Dörks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Dörks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Dörks more than expected).
Fields of papers citing papers by Michael Dörks
This network shows the impact of papers produced by Michael Dörks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Dörks. The network helps show where Michael Dörks may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Dörks, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 45 | |
| 2 | 2017 | 44 | |
| 3 | 2016 | 43 | |
| 4 | 2015 | 39 | |
| 5 | 2016 | 30 | |
| 6 | 2016 | 29 | |
| 7 | 2016 | 28 | |
| 8 | 2012 | 27 | |
| 9 | 2017 | 19 | |
| 10 | 2017 | 19 | |
| 11 | 2018 | 18 | |
| 12 | 2021 | 16 | |
| 13 | 2016 | 15 | |
| 14 | 2019 | 13 | |
| 15 | 2017 | 12 | |
| 16 | 2021 | 12 | |
| 17 | 2021 | 11 | |
| 18 | 2023 | 11 | |
| 19 | 2016 | 10 | |
| 20 | 2017 | 10 |
About Michael Dörks
Michael Dörks is a scholar working on Geriatrics and Gerontology, Pediatrics, Perinatology and Child Health, Psychiatry and Mental health, Toxicology and Cardiology and Cardiovascular Medicine, having authored 32 papers that have together received 469 indexed citations. Recurring topics across this work include Pharmaceutical Practices and Patient Outcomes (12 papers), Pharmaceutical studies and practices (5 papers), Schizophrenia research and treatment (4 papers), Atrial Fibrillation Management and Outcomes (4 papers), Pharmacovigilance and Adverse Drug Reactions (3 papers), Treatment of Major Depression (3 papers), Inhalation and Respiratory Drug Delivery (2 papers) and Mental Health Treatment and Access (2 papers). The work is most often cited by research in Geriatrics and Gerontology (153 citations), Toxicology (27 citations), Pediatrics, Perinatology and Child Health (59 citations), Psychiatry and Mental health (77 citations) and Pharmacology (43 citations). Michael Dörks has collaborated with scholars based in Germany, Canada and Austria. Frequent co-authors include Falk Hoffmann, Guido Schmiemann, Stefan Herget‐Rosenthal, Edeltraut Garbe, Katharina Allers, Antje Timmer, Ingo Langner, Kathrin Jobski, Oliver Riedel and Tilo Blenk. Their work appears in journals such as Pharmacoepidemiology and Drug Safety, European Child & Adolescent Psychiatry, Journal of the American Geriatrics Society, International Clinical Psychopharmacology and Journal of the American College of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.